Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Cancer, Lipids, and Metabolism, and Ferroptosis and cancer prognosis.
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
Pan-cancer genomic analysis reveals <i>FOXA1</i> amplification is associated with adverse outcomes in non–small cell lung, prostate, and breast cancers
Racial Disparities in Glioblastoma Genomic Alterations: A Comprehensive Analysis of a Multi-Institution Cohort of 2390 Patients
Disparities in Diagnosis, Treatment Access, and Time to Treatment Among Hispanic Men With Metastatic Prostate Cancer
Genomic Characterization of Aggressive Breast Cancer in Younger Women
Determinants of widespread metastases and of metastatic tropism in patients with prostate cancer: A genomic analysis of primary and metastatic tumors
Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men
Racial Differences in Genomic Profiles of Breast Cancer
Clinicogenomic characterization of prostate cancer liver metastases
Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair
The long noncoding RNA H19 regulates tumor plasticity in neuroendocrine prostate cancer
Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences
Pan-cancer Transcriptomic Predictors of Perineural Invasion Improve Occult Histopathologic Detection
Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer
The DNA methylation landscape of advanced prostate cancer
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity
Racial Differences in Genomic Profiling of Prostate Cancer
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance
High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program
Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a <i>de novo</i> low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer
Novel RB1-Loss Transcriptomic Signature Is Associated with Poor Clinical Outcomes across Cancer Types
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications
The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer
Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
TOP2A and EZH2 Provide Early Detection of an Aggressive Prostate Cancer Subgroup
Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome
Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis